Skip to Content
Merck
Search Within
Document Type

ibuprofen

Applied Filters:
Keyword:'ibuprofen'
Showing 1-30 of 56 results for "ibuprofen" within Technical Documents
Ibuprofen and Codeine MM
Application Note: Fast analytical separations - Ibuprofen and Codeine using Chromolith HighResolution Merck Millipore is a division of Merck KGaA, Darmstadt, Germany http://www.merckmillipore.com
Cyclodextrin HPB: the effective route to inreased API solubility and stability
at io n [m m ol /L ] Cyclodextrin HPB concentration [%] Ibuprofen HP-β-CD Solubility Ibuprofen [mmol/L] Mode of Action Cyclodextrins are cyclic oligosaccharides derived
Cyclodextrins Flyer
at io n [m m ol /L ] Cyclodextrin HPB concentration [%] Ibuprofen HP-β-CD Solubility Ibuprofen [mmol/L] Mode of Action Cyclodextrins are cyclic oligosaccharides derived
Data Sheet - I0386
I0386-91k8803.doc IBUPROFEN Methanol Solution Product Number I 0386 Lot Number 91K8803 CAS Number [15687-27-1] Concentration 1.01 mg Ibuprofen/mL GC grade methanol (conc
Rationale for a Small Molecule Non-Specific Binding; 2002
factors Negative Charge foscarnet sodium methotrexate thiopental sodium taurocholate ketoprofen ibuprofen olsalazine piroxicam naproxen acetylsalicylic acid warfarin hydrochlorothiazide fluvastatin Positive
Parteck®ODT Excipient
Fig. 3: Disintegration profile of API formulation with Parteck® ODT vs. competitors. 200 mg ibuprofen + 1 % SiO2 + 1 % Mg stearate, Korsch EK 0 DMS, 500 mg tablets, diameter 11 mm, flat, facetted
Parteck® ODT Excipient: Right here - Right now
Disintegration profile of API formulation with Parteck® ODT excipient vs. competitors. 200 mg ibuprofen + 1 % SiO2 + 1 % Mg stearate, Korsch EK 0 DMS, 500 mg tablets, diameter 11 mm, flat, facetted
Parteck® LM Excipient System Reduce complexity in your formulation and optimize results
170** 170** 0.37** Ibuprofen 200 mg 40% Parteck ® LM High + 40% Ibuprofen + 20% MCC, Type 102 500 mg; Ø 11mm, flat & facetted 102 1.21 0.27 239 - 302 300 0.96 Ibuprofen/Parteck® SLC 37.5 mg
White Paper - How to Select the Optimal ODT Excipient System
which the disintegration and dissolution properties of tablet formulations made with a model API (ibuprofen) and five ready-to-use ODT excipient systems were evaluated. 10 The life science business of
MultiScreen Solubility Filter plate: Integration with Detection Techniques
high 500 20 ß-estradiol low sum 21b 21 clotrimazole low sum 1 22 digoxin low sum 83 b 23 ibuprofen low sum 500 b 24 mannitol low sum 500 b 25 taxol low sum
High throughput sample preparation for the quantitation of drug compounds in serum samples
of eight different compounds (digoxin, propranolol, taxol, testosterone, verapamil, warfarin, ibuprofen, and methotrexate) was measured in multiple wells of different MultiScreen Solvinert filter plates
Impurities & Related Compounds: Reference Materials
COMPOUND A IBUPROFEN IBUPROFEN RELATED COMPOUND C IBUPROFEN IMPURITY A IBUPROFEN IMPURITY B IBUPROFEN IMPURITY F IBUPROFEN IMPURITY J IBUPROFEN IMPURITY G IBUPROFEN IMPURITY H
Levetiracetam and Caffeine MM
[email protected] Levetiracetam and Caffeine Chromolith® HighResolution RP-18endcapped Ibuprofen -10 190 390 590 0 0,5 1 1,5 2 2,5 3 3,5 4 4,5 5 In te
The Samplicity®System Delivers High-Performance Multi-sample Filtration
% 0.91 Ranitidine 96.5 % 0.76 Ibuprofen 100.12 % 0.13 0.20 µm Acetaminophen 99.9 % 1.64 Loratadine 96.16 % 0.74 Ranitidine 99.17 % 0.52 Ibuprofen 99.99 % 0.12 Table 2. High recovery
Brochure: Watercol Capillary GC Columns
Size: GC results can be obtained using small sample sizes, such as ibuprofen. Selectivity Options: Whether water is an analyte or the injection solvent – see Figure
White paper: Platform Formulation Technology to De-Risk Solid-State Variation in Drug Development
nm (disordered) * By the U.S. Food and Drug Administration ** Parteck® SLC loaded with 30% ibuprofen. Density is increased upon loading with API. The Life Science business of Merck operates
Product Information Sheet - G5502
36, 7-10 (2001) (article in Japnese). 8. Fossati, A., et al., Effects of metoxibutropate, ibuprofen and guaiacol on the gastrointestinal system. 13, 45-50 (1991). HLD/AJH 8/05 Sigma
MultiScreen Caco-2 Optimization of MDCK cell growth and differentiation for drug transport assay studies using a 96-well assay system
or 14C radio-labeled drug to monitor the drug transport rate. [Unlabeled caffeine (cat. C8960), ibuprofen (cat. I4883) and propranolol (cat. P08840) were all purchased from Sigma Chemical Company (St. Louis
141464 Parteck®MXP. Technical Information.
API. API (BCS II) MW (g/mol) pKa Tm (°C) LogP Charge Aqueous solubility (mg/mL, 25 °C) Ibuprofen 206.28 4.91 78 3.97 -1 0.021 Cinnarizine 368.51 8.4 118 – 122 5.19 1 0.00172 Ketoconazole
141464 Parteck MXP
API. API (BCS II) MW (g/mol) pKa Tm (°C) LogP Charge Aqueous solubility (mg/mL, 25 °C) Ibuprofen 206.28 4.91 78 3.97 -1 0.021 Cinnarizine 368.51 8.4 118 – 122 5.19 1 0.00172 Ketoconazole
The Importance of Water Quality in LC-MS
Carbamazepine 78 (800) 25 (110) 75 (294) 70 (370) Diclofenac 18 (41) 150 (1200) 20 (64) 15 (40) Ibuprofen 23 (120) 70 (530) ND 10 (65) Iopromide 7 (17) 100 (910) 91 (211) - Sulfamethoxazole 25 (133) 30
MultiScreen Caco-2 --Drug Transport Assembly in a 96-well system:
D6003), mannitol (cat. M9546), paclitaxel (Taxol®) (cat. T1912), prednisone (cat. P6254), ibuprofen (cat. I1892), verapamil (cat. V4629), warfarin (cat. A2250) and methotrexate (cat. M8407
Continuous Manufacturing - how to overcome feeding challenge of Magnesium stearate
at 20 kN. The suitability of the excipient system is also demonstrated with other model drugs (Ibuprofen, Ascorbic acid) showing comparable or even lower ejection forces for the excipient system (data
Product Information Sheet - SE120083
, Diazepam, Ethosuximide, Estriol, Estrone, Estradiol, Ethotoin, Glutethimide , Hexobarbital, Ibuprofen, Imipramine, Lidocaine, LSD, Methadone , Methadone- primary metabolite, Methaqualone, Methamphetamine
Data Sheet - L6787
Hydrochlorothiazide H9382 3-Hydroxybenzylhydrazine dihydrochloride I2142 KN-62 I4883 (±)-Ibuprofen I7016 H-7 dihydrochloride I7378 Indomethacin I7627 Iproniazid phosphate I8021 L-N6-(
Product Information - L6787
Hydrochlorothiazide H9382 3-Hydroxybenzylhydrazine dihydrochloride I2142 KN-62 I4883 (±)-Ibuprofen I7016 H-7 dihydrochloride I7378 Indomethacin I7627 Iproniazid phosphate I8021 L-N6-(
Brochure: Parteck® SLC Excipient: Drug Substance, meet Drug Product
Paracetamol (PAR) 29 0.91 151 9.5 (acidic) I Posaconazole (POS) 28 5.5 701 3.7 (basic) II Ibuprofen 30 3.97 207 5.3 (acidic) II Carbamazepine 29 2.77 236 – (neutral) II Haloperidol 30 4.3 376
Understanding the stabilization mechanism of polyvinyl alcohols (Parteck® MXP) in ASDs by structure-related properties and PC-SAFT modeling
Itraconazole Tetralin Naproxen Artemisinin Indomethacin Nifedipine Ritonavir Ibuprofen Paracetamol Acetylsalicylic acid Thiabendazole Sulfathiazole Sulfamerazine Sulfadiazine
Parteck®Product Folder
side eff ects. API Tm of API (ºC) Loading (%) Solubility Enhancement (max.) Ibuprofen* 78 min. 30 2-fold Cinnarizine 118 – 122 < 20 10-fold Indomethacin 151 min. 30 3-fold
Millex&reg; Sırınga Ucu Filtreler ve Samplicity¿ Filtrasyon Sistemi
90% 80% 70% 60% 50% 40% 0 1 2 3 4 5 6 7 8 9 10 11 Ranitidine Acetaminophen Ibuprofen Loratidine 100% Pe rc en t D ru g Re co ve ry 90%
Page 1 of 2